Shopping Cart 0
Cart Subtotal
USD 0

AxoGen Inc (AXGN) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company offers products such as AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among others. It also offers clinical research studies in understanding and outcome of peripheral nerve regeneration and reconstruction projects. AxoGen's clinical research programs comprise the CHANGE study, the RANGER study, and the RECON study programs. The company provide regulations for human tissue products and medical devices. It operates distribution centers in Burleson. AxoGen is headquartered in Alachua, Florida, the US.

AxoGen Inc (AXGN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

AxoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

AxoGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

AxoGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

AxoGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

AxoGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

AxoGen Inc, Medical Equipment, Deal Details 10

Equity Offering 10

AxoGen Raises USD141.4 Million in Public Offering of Shares 10

AxoGen Raises USD41 Million in Public Offering of Shares 12

AxoGen Plans to Raise up to USD92.2 Million in Public Offering of Shares 14

AxoGen Raises USD20 Million in Public Offering of Shares 15

AxoGen Raises USD17.5 Million in Private Placement of Shares 17

AxoGen Raises USD15 Million in Public Offering of Shares 19

AxoGen Completes Underwriters' Exercise Of Partial Over-Alotment Option Of Public Offering Of Shares For USD 18.6 Million 20

AxoGen Completes Second Tranche Of Private Placement For USD 19 Million 21

AxoGen Inc-Key Competitors 22

AxoGen Inc-Key Employees 23

AxoGen Inc-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Financial Announcements 25

Aug 01, 2018: AxoGen reports 2018 second quarter financial results 25

Apr 30, 2018: AxoGen Announces 2018 First Quarter Financial Results 27

Feb 28, 2018: AxoGen Reports 2017 Fourth Quarter and Full Year Financial Results 28

Jan 08, 2018: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue 30

Nov 01, 2017: AxoGen Reports 2017 Third Quarter Financial Results 31

Aug 02, 2017: AxoGen Reports 2017 Second Quarter Financial Results 32

May 04, 2017: AxoGen Reports 2017 First Quarter Financial Results 33

Feb 22, 2017: AxoGen Reports 2016 Fourth Quarter and Full Year Financial Results 34

Jan 09, 2017: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2016 Revenue 36

Corporate Communications 37

Jul 10, 2018: AxoGen Names Lisa N. Colleran As Board Director 37

Jun 04, 2018: AxoGen Names Kaila Krum Vice President, Investor Relations and Corporate Development 38

May 21, 2018: AxoGen Names Karen Zaderej As Board Chairman 39

Oct 18, 2017: AxoGen Receives David J. Gury Company of the Year Award from BioFlorida 40

Jul 17, 2017: AxoGen Appoints Jon Gingrich Chief Commercial Officer 41

Jan 05, 2017: AxoGen Appoints Ivica Ducic Medical Director 42

Product News 43

Nov 20, 2017: AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day 43

Appendix 45

Methodology 45

About GlobalData 45

Contact Us 45

Disclaimer 45


List Of Figure

List of Figures

AxoGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

AxoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

AxoGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

AxoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

AxoGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

AxoGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

AxoGen Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

AxoGen Inc, Medical Equipment, Key Facts, 2017 2

AxoGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

AxoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

AxoGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

AxoGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

AxoGen Inc, Deals By Market, 2012 to YTD 2018 8

AxoGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

AxoGen Raises USD141.4 Million in Public Offering of Shares 10

AxoGen Raises USD41 Million in Public Offering of Shares 12

AxoGen Plans to Raise up to USD92.2 Million in Public Offering of Shares 14

AxoGen Raises USD20 Million in Public Offering of Shares 15

AxoGen Raises USD17.5 Million in Private Placement of Shares 17

AxoGen Raises USD15 Million in Public Offering of Shares 19

AxoGen Completes Underwriters' Exercise Of Partial Over-Alotment Option Of Public Offering Of Shares For USD 18.6 Million 20

AxoGen Completes Second Tranche Of Private Placement For USD 19 Million 21

AxoGen Inc, Key Competitors 22

AxoGen Inc, Key Employees 23

AxoGen Inc, Other Locations 24

AxoGen Inc, Subsidiaries 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

AxoGen Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.